BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 2167146)

  • 1. Better survival after combined modality care for adults with Wilms' tumor. A report from the National Wilms' Tumor Study.
    Arrigo S; Beckwith JB; Sharples K; D'Angio G; Haase G
    Cancer; 1990 Sep; 66(5):827-30. PubMed ID: 2167146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of two radiation therapy randomizations in the third National Wilms' Tumor Study.
    Thomas PR; Tefft M; Compaan PJ; Norkool P; Breslow NE; D'Angio GJ
    Cancer; 1991 Oct; 68(8):1703-7. PubMed ID: 1655223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Green DM; Breslow NE; Evans I; Moksness J; D'Angio GJ
    Med Pediatr Oncol; 1996 Mar; 26(3):147-52. PubMed ID: 8544795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study.
    Pritchard J; Imeson J; Barnes J; Cotterill S; Gough D; Marsden HB; Morris-Jones P; Pearson D
    J Clin Oncol; 1995 Jan; 13(1):124-33. PubMed ID: 7799012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy PE; Thomas PR; Kim T; Shochat SJ; Haase GM; Ritchey ML; Kelalis PP; D'Angio GJ
    J Clin Oncol; 1998 Jan; 16(1):237-45. PubMed ID: 9440748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study.
    D'Angio GJ; Breslow N; Beckwith JB; Evans A; Baum H; deLorimier A; Fernbach D; Hrabovsky E; Jones B; Kelalis P
    Cancer; 1989 Jul; 64(2):349-60. PubMed ID: 2544249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Beckwith JB; Breslow NE; Faria P; Moksness J; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S
    J Clin Oncol; 1994 Oct; 12(10):2126-31. PubMed ID: 7931483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies.
    Breslow NE; Ou SS; Beckwith JB; Haase GM; Kalapurakal JA; Ritchey ML; Shamberger RC; Thomas PR; D'Angio GJ; Green DM
    Cancer; 2004 Sep; 101(5):1072-80. PubMed ID: 15329918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
    Daw NC; Chi YY; Kim Y; Mullen EA; Kalapurakal JA; Tian J; Khanna G; Geller JI; Perlman EJ; Ehrlich PF; Warwick AB; Grundy PE; Fernandez CV; Dome JS;
    Eur J Cancer; 2019 Sep; 118():58-66. PubMed ID: 31325873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of Wilms' tumor trial (WT-99) in Shanghai children's medical center].
    Tang JY; Pan C; Xu M; Xue HL; Chen J; Zhao HL; Gu LL; Wang YP
    Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):131-4. PubMed ID: 14759320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S; Haase G; Ritchey M; Kelalis P; D'Angio GJ
    J Clin Oncol; 1998 Dec; 16(12):3744-51. PubMed ID: 9850017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
    Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Acha T; Godzinski J; Oldenburger F; Boccon-Gibod L; Leuschner I; Vujanic G; Sandstedt B; de Kraker J; van Tinteren H; Graf N;
    Lancet; 2015 Sep; 386(9999):1156-64. PubMed ID: 26164096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor.
    Tournade MF; Com-Nougué C; Voûte PA; Lemerle J; de Kraker J; Delemarre JF; Burgers M; Habrand JL; Moorman CG; Bürger D
    J Clin Oncol; 1993 Jun; 11(6):1014-23. PubMed ID: 8388918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
    Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM;
    J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study.
    D'Angio GJ; Evans A; Breslow N; Beckwith B; Bishop H; Farewell V; Goodwin W; Leape L; Palmer N; Sinks L; Sutow W; Tefft M; Wolff J
    Cancer; 1981 May; 47(9):2302-11. PubMed ID: 6164480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute toxicities associated with radiation in the second National Wilms' Tumor Study.
    Thomas PR; Tefft M; D'Angio GJ; Norkool P
    J Clin Oncol; 1988 Nov; 6(11):1694-8. PubMed ID: 2846791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Wilms' tumour. Current recommendations.
    Mehta MP; Bastin KT; Wiersma SR
    Drugs; 1991 Nov; 42(5):766-80. PubMed ID: 1723373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal therapy for adult Wilms' tumour: an experience from one centre.
    Li JJ; Huang HH; Shen J; Jiang JY; Pan F; Yu ST; Kang Y; Zhao XX; Yan XC; Liang HJ
    Clin Transl Oncol; 2011 Sep; 13(9):672-6. PubMed ID: 21865139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of children with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Moksness J; Finklestein JZ; D'Angio GJ
    J Clin Oncol; 1994 Oct; 12(10):2132-7. PubMed ID: 7931484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.